Compare NGD & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NGD | MMS |
|---|---|---|
| Founded | N/A | 1975 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Business Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.7B |
| IPO Year | 2004 | 1997 |
| Metric | NGD | MMS |
|---|---|---|
| Price | $7.90 | $83.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.75 | ★ $90.00 |
| AVG Volume (30 Days) | ★ 17.3M | 657.0K |
| Earning Date | 10-28-2025 | 11-20-2025 |
| Dividend Yield | N/A | ★ 1.47% |
| EPS Growth | ★ 1232.42 | 10.42 |
| EPS | 0.31 | ★ 5.51 |
| Revenue | $1,242,200,000.00 | ★ $5,431,276,000.00 |
| Revenue This Year | $62.14 | $1.71 |
| Revenue Next Year | $57.44 | $4.98 |
| P/E Ratio | $24.86 | ★ $14.85 |
| Revenue Growth | ★ 44.19 | 2.36 |
| 52 Week Low | $2.43 | $63.77 |
| 52 Week High | $8.62 | $92.50 |
| Indicator | NGD | MMS |
|---|---|---|
| Relative Strength Index (RSI) | 57.67 | 48.09 |
| Support Level | $7.44 | $81.65 |
| Resistance Level | $8.17 | $87.92 |
| Average True Range (ATR) | 0.41 | 2.49 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 62.32 | 45.11 |
New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets which are also its operating segments: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.